Drug-drug interactions and AI: keeping prescribing safe

Three ways to see it

1. 1

   Drug interaction systems combine three things: a curated knowledge base of known interactions, a patient medication list, and an alerting policy. The knowledge base must reflect the drugs commonly used in Pakistan, including local brand names and generics. The patient list must be up to date, which is hard when patients buy over the counter, see multiple doctors, and stop drugs without telling anyone. The alerting policy decides what to surface, when, and how loudly.

2. 2

   Alert fatigue is the silent killer of these systems. If every prescription throws three warnings the doctor learns to dismiss them all, including the one that matters. Tier alerts: severe and well-documented interactions block until acknowledged; moderate interactions show a passive note; theoretical or low-evidence interactions are excluded from the default view. Let senior pharmacologists tune the list quarterly.

3. 3

   Integration with pharmacies matters. Many Pakistani patients buy from neighborhood pharmacies that do not see the hospital record. A linkage between the e-prescription and the pharmacy point of sale, with patient consent, lets a final interaction check happen at dispensing. This avoids the gap where a doctor's clean prescription combines badly with a previously dispensed drug the system did not know about.

The why-tree

Try this with Claude

Pilot recipe. One: pick five drug classes with the highest local interaction burden such as macrolides, anticoagulants, antiepileptics, antiretrovirals, and statins. Two: import a curated database of severe interactions for these classes only. Three: run for two weeks on a single OPD and log every alert and every override. Four: have a pharmacologist review overrides weekly. Five: expand only after the override rate is below twenty percent and no severe alert was overridden in error.